![](/img/cover-not-exists.png)
A phase II study of oxaliplatin, docetaxel, and GM-CSF in patients with previously treated advanced melanoma
Frederick Locke, Joseph I. Clark, Thomas F. GajewskiVolume:
65
Language:
english
Pages:
6
DOI:
10.1007/s00280-009-1057-y
Date:
February, 2010
File:
PDF, 268 KB
english, 2010